Antibiotic Prophylaxis in Transcatheter Treatment of Hepatocellular Carcinoma: an Open Randomized Prospective Study of Oral Versus Intravenous Administration

Abstract

Our study findings suggest that the results of peroral administration of LVFX for the prevention of post-procedure infectious complications in patients receiving TACE/TAI for HCC are not inferior to those of intravenous administration of CEZ.